...
首页> 外文期刊>American Journal of Transplantation >Severe Vascular Lesions and Poor Functional Outcome in Kidney Transplant Recipients with Lupus Anticoagulant Antibodies
【24h】

Severe Vascular Lesions and Poor Functional Outcome in Kidney Transplant Recipients with Lupus Anticoagulant Antibodies

机译:狼疮抗凝抗体的肾脏移植受者的严重血管病变和功能不良

获取原文
获取原文并翻译 | 示例
           

摘要

The impact of antiphospholipid antibodies (APA) on clinical outcome and graft histology following renal transplantation remains poorly known and controversial. We retrospectively explored the functional and histological significance of APA, primarily lupus anticoagulant (LA), in kidney transplant recipients using a systematic evaluation of 3- and 12-month posttransplant screening biopsies and glomerular filtration rate measurements (mGFR). During the study period, 37 patients had APA (2.7%), primarily LA, and 12 fulfiled antiphospholipid syndrome (APS) diagnostic criteria (0.8%) at the time of transplantation. Early after transplantion, 4 of the 12 APS patients died. Early thrombosis of graft vessels and deep venous thrombosis occurred more frequently in APA+ patients than in controls (27% vs. 7%, p < 0.05 and 35% vs. 14%, p < 0.05, respectively). The survival rate was significantly lower in patients with APS. Strikingly, the hallmark lesions of APS-associated nephropathy (APSN) were found in most of screening graft biopsies in APA+ patients but not in the controls. Accordingly, APA+ patients had a dramatic increase in chronic vascular scores and a faster decline in mGFR at 1 year. In conclusion, renal transplantation may be life-threatening in APS patients, and the presence of LA at the time of transplantation is associated with a high rate of allograft APSN and poor transplantation outcomes.
机译:肾移植后抗磷脂抗体(APA)对临床结局和移植组织学的影响仍然知之甚少,并引起争议。我们通过对移植后3个月和12个月的活检和肾小球滤过率测量(mGFR)进行系统评估,回顾性研究了肾移植受体中APA(主要是狼疮抗凝剂(LA))的功能和组织学意义。在研究期间,有37例患者在移植时具有APA(2.7%),主要是LA和12项充分的抗磷脂综合症(APS)诊断标准(0.8%)。移植后早期,12例APS患者中有4例死亡。与对照组相比,APA +患者的血管早期血栓形成和深静脉血栓形成发生率更高(分别为27%vs. 7%,p <0.05和35%vs. 14%,p <0.05)。 APS患者的生存率显着降低。引人注目的是,在APA +患者的大多数筛查活检组织中发现了APS相关性肾病(APSN)的标志性病变,但在对照中却没有发现。因此,APA +患者在1年时的慢性血管评分显着增加,而mGFR下降更快。总之,肾移植可能会威胁APS患者的生命,并且移植时存在LA与同种异体移植APSN的高发生率和不良的移植结果有关。

著录项

  • 来源
    《American Journal of Transplantation》 |2010年第9期|p.2051-2060|共10页
  • 作者单位

    Université Paris Descartes, Paris, France|Service de Transplantation et Unité de Soins Intensifs|INSERM U845, Centre de recherche croissance et signalisation;

    Université Paris Descartes, Paris, France|INSERM U845, Centre de recherche croissance et signalisation|Service d’explorations fonctionnelles;

    Université Paris Descartes, Paris, France|Laboratoire d’Anatomopathologie;

    Université Paris Descartes, Paris, France|Laboratoire d’Anatomopathologie;

    Université Paris Descartes, Paris, France|Laboratoire d’Immunologie;

    Université Paris Descartes, Paris, France|Laboratoire d’Hématologie, Hôpital Necker, Paris, France;

    Université Paris Descartes, Paris, France|Service de Transplantation et Unité de Soins Intensifs;

    Service de Transplantation et Unité de Soins Intensifs;

    Université Paris Descartes, Paris, France|Service de Transplantation et Unité de Soins Intensifs;

    Université Paris Descartes, Paris, France|Service de Transplantation et Unité de Soins Intensifs;

    Université Paris Descartes, Paris, France|Service de Transplantation et Unité de Soins Intensifs;

    Université Paris Descartes, Paris, France|Service de Transplantation et Unité de Soins Intensifs;

    Université Paris Descartes, Paris, France|Service de Transplantation et Unité de Soins Intensifs;

    Université Paris Descartes, Paris, France|Service de Transplantation et Unité de Soins Intensifs;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Anticardiolipin antibodies; Banff lesions; glomerular filtration rate; thrombosis and kidney transplantation; transplant vascular sclerosis; vascular disease;

    机译:抗心磷脂抗体;班夫病灶;肾小球滤过率;血栓形成和肾脏移植;移植血管硬化;血管疾病;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号